Hepion Pharmaceuticals, Inc.

The current price of HEPA is 2.11 USD — it has decreased by 0.85% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Hepion Pharmaceuticals, Inc. stocks are traded under the ticker HEPA.

Hepion Pharmaceuticals, Inc. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.

HEPA stock is 8.32% volatile and has beta coefficient of 0.85. Check out the list of the most volatile stocks — is Hepion Pharmaceuticals, Inc. there?

HEPA earnings for the last quarter are −3.69 USD whereas the estimation was −3.41 USD which accounts for −8.21% surprise. Estimated earnings for the next quarter are −2.68 USD. See more details about Hepion Pharmaceuticals, Inc. earnings.

Yes, you can track Hepion Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.

HEPA net income for the last quarter is ‪−11.06 M‬ USD, while the quarter before that showed ‪−10.53 M‬ USD of net income which accounts for −5.06% change. Track more Hepion Pharmaceuticals, Inc. financial stats to get the full picture.

Today Hepion Pharmaceuticals, Inc. has the market capitalization of ‪9.24 M‬, it has increased by 11.79% over the last week.

No, HEPA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, HEPA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hepion Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.

HEPA reached its all-time high on Oct 5, 2015 with the price of 70336.00 USD, and its all-time low was 1.49 USD and was reached on Feb 9, 2024.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 22.00 employees. See our rating of the largest employees — is Hepion Pharmaceuticals, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Hepion Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Hepion Pharmaceuticals, Inc. stock shows the sell signal. See more of Hepion Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.